Spencer Z. Rosero
Technik-/Wissenschafts-/F&E-Leiter bei Efferent Labs, Inc.
Profil
Spencer Z.
Rosero is the founder of Physiologic Communications LLC, founded in 2004.
He is currently the Director & Chief Medical Officer at Efferent Labs, Inc. and a Professor at the University of Rochester.
Aktive Positionen von Spencer Z. Rosero
| Unternehmen | Position | Beginn |
|---|---|---|
| Rochester Christian University | Corporate Officer/Principal | - |
Efferent Labs, Inc.
 Efferent Labs, Inc. BiotechnologyHealth Technology Efferent Labs, Inc. operates as a preclinical stage biotechnology company. The firm focuses on implantable biosensors for life sciences. Its CytoComm biosensor platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases. The company was founded by William K. Rader and is headquartered in Buffalo, NY. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Spencer Z. Rosero
| Unternehmen | Position | Ende |
|---|---|---|
Physiologic Communications LLC
 Physiologic Communications LLC Medical SpecialtiesHealth Technology Physiologic Communications LLC designs and develops implantable electronic devices. It offers implantable wireless biosensors that integrate living cells and a tool to monitor biochemical signals. The company was founded by Spencer Z. Rosero on July 12, 2004 and is headquartered in Rochester, NY | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Physiologic Communications LLC
Physiologic Communications LLC Medical SpecialtiesHealth Technology Physiologic Communications LLC designs and develops implantable electronic devices. It offers implantable wireless biosensors that integrate living cells and a tool to monitor biochemical signals. The company was founded by Spencer Z. Rosero on July 12, 2004 and is headquartered in Rochester, NY | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Efferent Labs, Inc. operates as a preclinical stage biotechnology company. The firm focuses on implantable biosensors for life sciences. Its CytoComm biosensor platform has multiple applications including preclinical R&D, clinical testing, oncology, cardiology, and metabolic diseases. The company was founded by William K. Rader and is headquartered in Buffalo, NY. | Health Technology |
